Medley First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Medley (TSE:4480) First Quarter 2025 Results

Key Financial Results

• Revenue: JP¥8.14b (up 37% from 1Q 2024).
• Net loss: JP¥75.0m (down by 116% from JP¥466.0m profit in 1Q 2024).
• JP¥2.32 loss per share (down from JP¥14.37 profit in 1Q 2024).

This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Medley Revenues Beat Expectations, EPS Falls Short

Revenue exceeded analyst estimates by 2.6%. Earnings per share (EPS) missed analyst estimates by 156%.

Looking ahead, revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Healthcare Services industry in Japan.

Performance of the Japanese Healthcare Services industry.

The company's shares are down 11% from a week ago.

Risk Analysis

It is worth noting though that we have found 1 warning sign for Medley that you need to take into consideration.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.